Nazumamide A is a natural compound classified as a cyclic peptide, originally isolated from marine organisms, particularly certain species of marine bacteria. It exhibits a unique structure characterized by a cyclic arrangement of amino acids, which contributes to its biological activity. This compound has garnered interest in the field of medicinal chemistry due to its potential pharmacological properties, including antimicrobial and anticancer activities. Nazumamide A has been studied for its ability to inhibit specific enzymes and cellular processes, making it a candidate for further research in drug development. Its solubility and stability in various solvents can vary, which is important for its application in biological assays. Additionally, the compound's synthesis and modification have been explored to enhance its efficacy and reduce toxicity. Overall, nazumamide A represents a fascinating example of how natural products can lead to the discovery of novel therapeutic agents.

nazumamide A

138949-86-7: Nazumamide A is a natural compound classified as a cyclic peptide, originally isolated from marine organisms, particularly certain species of marine bacteria. It exhibits a unique structure characterized by a cyclic arrangement of amino acids, which contributes to its biological activity. This compound has garnered interest in the field of medicinal chemistry due to its potential pharmacological properties, including antimicrobial and anticancer activities. Nazumamide A has been studied for its ability to inhibit specific enzymes and cellular processes, making it a candidate for further research in drug development. Its solubility and stability in various solvents can vary, which is important for its application in biological assays. Additionally, the compound's synthesis and modification have been explored to enhance its efficacy and reduce toxicity. Overall, nazumamide A represents a fascinating example of how natural products can lead to the discovery of novel therapeutic agents.

<p>Nazumamide A is a cyclic peptide with inhibitory activity against serine proteases. It binds to the active site of thrombin and inhibits its action, thereby inhibiting the fibrinogen degradation in blood. Nazumamide A is also found to have neuroprotective properties, which may be due to its ability to inhibit nitric oxide production by binding to the enzyme nitric oxide synthase. It has been shown to have anti-inflammatory activities and can be used for the treatment of inflammation-associated diseases such as asthma and arthritis. Nazumamide A is a nonribosomal peptide that does not require any cofactors for synthesis.</p>

CAS 138949-86-7

nazumamide A

Nazumamide A

Ref: 3D-FN111036